Medytox won a lawsuit against the Ministry of Food and Drug Safety (MFDS) in a three-year battle over the product approval cancellation of its Meditoxin lineup, its botulinum toxin (BTX) product, for alleged use of unauthorized raw materials.According to Medytox, the Daejeon District Court ruled in
Despite a remarkable surge in the sales of its flagship product, Xcopri, an epilepsy drug, in the U.S., SK biopharmaceuticals is still facing an operating loss, which raises concerns about the company's financial health.In the third quarter, Xcopri achieved record-breaking sales of 75.7 billion won
Lunit said it will supply its AI-powered chest screening solution, Lunit INSIGHT CXR, to a military hospital and public health center in the Philippines.The company will install its solution at Victoriano Luna Medical Center, a military hospital in Manila, and at a local public health center in Gene
Amid recent performance struggles, GC, one of Korea's leading pharmaceutical companies and vaccine makers, has initiated significant steps to restructure its organization and workforce.According to industry officials, GC has started accepting early retirement program (ERP) applications from employee
Kolon Pharma said it has signed a joint development agreement with GBiologics to develop a new drug for systemic lupus erythematosus that seeks to suppress B cells and plasmacytoid dendritic cells (pDC) simultaneously. Under the accord, both companies plan to conduct joint research and development f
The Celltrion Group's strategic merger of Celltrion and Celltrion Healthcare has garnered a significant boost following the Korean government's recent prohibition on short selling and the companies' announcement of unprecedented quarterly earnings.The positive developments have pushed stock prices o
Gilead Sciences Korea is seeking insurance coverage of its new drug Trodelvy (ingredient: sacituzumab govitecan) for the treatment of triple-negative breast cancer (TNBC).Speaking at a press conference celebrating the launch of the drug at the Plaza Hotel on Tuesday, the company said that it is curr
Research conducted by Seoul National University Bundang Hospital (SNUBH) revealed that trauma from accumulated harm or abuse during childhood period acts as a significant factor in the onset of mental illness in adulthood.The research team, led by Professor Kim Eui-tae of the Department of Neuropsyc
Orum Therapeutics said it has agreed to transfer all rights on ORM-6151, an acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome treatment candidate, to Bristol Myers Squibb (BMS) in a $180 million deal.Under the accord, BMS will pay Orum Therapeutics an upfront fee of $100 million and
Competition among Korean dermatology clinics is intensifying, despite earlier expectations of oversaturation in the dermatology and cosmetic medicine fields.A significant change has been observed in mole removal services, with prices significantly reduced. Clinics now offer inexpensive mole removal
Roche Korea said Lunsumio (ingredient: mosunetuzumab), a CD20/CD3 bispecific antibody, has received approval from the Ministry of Food and Drug Safety to treat adult patients with recurrent or refractory follicular lymphoma (FL) who have undergone two or more systemic therapies.Lunsumio is the first
Huons and Kakao Healthcare have joined hands to co-market Dexcom G7, a continuous glucose monitoring (CGM) device developed by Dexcom, with Kakao Healthcare.Under the contract, both parties aim to make Dexcom G7 the top-selling CGM device in Korea, and improve convenience for diabetes patients.The t
Severance Hospital said it has achieved a national record by securing the top position in the hospital medical service category of the National Customer Satisfaction Index (NCSI) for an unprecedented 13th consecutive year.According to the hospital, it was able to achieve such an accomplishment throu
Harim Co. is facing public backlash after its chairman, Kim Hong-kuk, claimed that insects found in a chicken purchased at a supermarket were "harmless to the human body."During a press conference held at a cinema in Gangnam-gu, Seoul, to celebrate the launch of the children's food brand Foodie Budd
MSD Korea said its 15-valent pneumococcal conjugate vaccine Vaxneuvance received approval from the Ministry of Food and Drug Safety on Tuesday.Vaxneuvance is the first pneumococcal vaccine to be authorized in Korea in 13 years and has expanded its preventative range by adding two serotypes, 22F and
Seoul National University Bundang Hospital (SNUBH), led by CEO & President Song Jung-han, is at the forefront of integrating public welfare with healthcare excellence, as it embraces the challenge of redefining patient care.Song, who took office as CEO and President of SNUBH in March, is a leading a
Biogen Korea is strengthening its position in the local spinal muscular atrophy (SMA) market with expanded reimbursement benefit of Spinraza (ingredient: nusinersen), the company said Thursday.Biogen Korea held a press conference at the Conrad Hotel in Yeouido, Seoul, Thursday, to commemorate the ex
Over the past year, 33 global pharmaceutical companies conducted 1,600 clinical trials in Korea, investing over 800 billion won ($596.1 million) in research costs. The amount was up 14.3 percent, compared to a year earlier.The 14.3 percent R&D growth in 2022 was slower than that of 2021, which stood
Helixmith, a Korean biotech firm focusing on gene therapy, is facing potential administrative measures from the Korea Exchange, having repeatedly delayed its capital increase payment deadlines over a span of six months.According to the Financial Supervisory Service's electronic disclosure system, th
The sudden proliferation of bed bugs in cities such as Daegu and Incheon has now reached Seoul, a capital with a population of 9.7 million people, and this is leading to a surge in demand for insect repellents.According to Dongsung Pharmaceutical, sales of their repellent Biokill in October have sky